Babel Ventures is a United States-based venture capital firm founded in 2017 and headquartered in San Francisco, California. The firm focuses on early-stage investments, primarily at the pre-seed, seed, and Series A stages. It specializes in consumer biotechnology and deep technology sectors, including healthcare, sustainability, and food innovation. Babel Ventures typically acts as an early institutional investor, providing initial capital alongside strategic support to emerging companies. Its investment approach centers on backing impact-oriented founders developing science-driven products with commercial applications.